Animal models of spontaneous pancreatic neuroendocrine tumors.
Pancreatic neuroendocrine tumors (PNETs) are usually low-grade neoplasms derived from the endocrine pancreas. PNETs can be functioning and cause well-described hormonal hypersecretion syndromes or non-functioning and cause only tumor mass effect. PNETs appear to be more common recently likely due to incidental detection by imaging. Although the diagnosis and management of PNETs have been evolving rapidly, much remains to be studied in the areas of molecular pathogenesis, molecular markers of tumor behavior, early detection, and targeted drug therapy. Unique challenges facing PNETs studies are long disease course, the deep location of pancreas and difficult access to pancreatic tissue, and the variety of tumors, which make animal models valuable tools for PNETs studies. Existing animal models of PNETs have provided insights into the pathogenesis and natural history of human PNETs. Future studies on animal models of PNETs should address early tumor detection, molecular markers of tumor behavior, and novel targeted therapies.
Division of Endocrinology, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: run.yu@cshs.org.
Run
R
Yu
D000818:Animals; D030801:Animals, Genetically Modified; D014408:Biomarkers, Tumor / Q000235:genetics*; D004195:Disease Models, Animal; D006801:Humans; D018358:Neuroendocrine Tumors / Q000235:genetics / Q000473:pathology*; D010190:Pancreatic Neoplasms / Q000235:genetics / Q000473:pathology*
D014408:Biomarkers, Tumor
Animal models; Murine models; Pancreatic neuroendocrine tumors